Study protocol of the e-Intervention Enhancing Mental Health in Adolescents (IMPROVA) project: a randomised controlled trial to promote adolescents' mental health and well-being in four European countries.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lima Rodrigo Antunes, Baumeister Harald, Pryss Rüdiger, Küchler Ann-Marie, Kraft Robin, Berghoff Nils, Nagel Luzia, Reichert Manfred, Idrees Abdul Rahman, Stach Michael, Melchior Maria, Davisse-Paturet Camille, Falkiner Emma, van der Waerden Judith, Baban Adriana, Taut Diana, Danila Ingrid, Perez-Anton Mariona, Porricelli Daniele, Sanguesa Julia, Moneta Maria Victoria, García-Carrión Rocío, Finkenauer Catrin, Stevens Gonneke Wjm, Krabbendam Lydia, Bolinski Felix, Maresova Petra, Nilsen Per, Karlsson Nadine, Moreno Natalia, Le Corvec Anaïs, Haro Josep Maria
Аннотация
METHODS AND ANALYSIS: The IMPROVA intervention will be evaluated using a two-arm parallel group pragmatic cluster randomised controlled trial with an intervention and a wait-list control group. Secondary schools in France, Germany, Romania, and Spain were recruited. Originally, we estimated to enrol a total of 6000 students within 64 schools; that is, 16 schools per country. The IMPROVA programme is a multi-level intervention that provides tailored content for adolescents, families, and school staff. This content creates a unified and supportive framework that promotes mental health and social-emotional development among adolescents. A series of implementation strategies was planned to support the uptake of the programme into the education setting and among participants. Study outcomes were assessed at baseline, mid-term (during the intervention), postintervention (primary end point), and will be assessed at postintervention (secondary end-point; 6 months after postintervention). Overall mental health (Strengths and Difficulties Questionnaire) is the primary outcome. Secondary outcomes include: health-related quality of life, depression, anxiety, social isolation, and self-esteem. The trial will be evaluated regarding its effectiveness, cost-effectiveness, implementation, and social return on investment analysis.
ETHICS AND DISSEMINATION: This study has received the approval of human research ethics committees in France (Comité de Protection des Personnes Ile-de-France VIII", No. 2024-A00201-46), Germany (Ulm University Ethics Committee, No. 186-24), Romania (The Research Ethics Subcommittee of the Babeș-Bolyai University of Cluj-Napoca, No. 14.146/23.09.2024), and Spain (CEIm Fundació Sant Joan de Déu, No. PIC-61-24). Results will be disseminated through peer-reviewed open-access publications and presentations at national and international conferences. Non-technical summaries will be shared with public health authorities, participants, and stakeholder organisations. All findings will be reported in aggregate form, ensuring no individual participant can be identified.
TRIAL REGISTRATION NUMBER: NCT06556576.